Adtalem Global Education (NYSE:CVSA) Updates FY 2027 Earnings Guidance

Adtalem Global Education (NYSE:CVSA) issued an update on its FY 2027 earnings guidance on Thursday morning. The company provided EPS guidance of 8.900-9.150 for the period, compared to the consensus estimate of 8.880. The company issued revenue guidance of $2.1 billion-$2.1 billion, compared to the consensus revenue estimate of $2.1 billion.

Adtalem Global Education Stock Down 3.0%

NYSE CVSA opened at $125.10 on Friday. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36. The company’s 50-day moving average price is $124.22. Adtalem Global Education has a twelve month low of $86.97 and a twelve month high of $156.26. The stock has a market capitalization of $4.26 billion, a P/E ratio of 19.49, a price-to-earnings-growth ratio of 0.97 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA) last posted its quarterly earnings data on Thursday, August 6th. The company reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. The firm had revenue of $501.38 million during the quarter. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. On average, equities analysts expect that Adtalem Global Education will post 8.04 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Truist Financial upped their target price on Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Wall Street Zen downgraded shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a research note on Saturday, July 25th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a research note on Monday, June 8th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, Adtalem Global Education has an average rating of “Moderate Buy” and an average target price of $155.00.

Insider Buying and Selling

In other Adtalem Global Education news, CFO Robert J. Phelan sold 2,414 shares of Adtalem Global Education stock in a transaction on Wednesday, July 8th. The stock was sold at an average price of $135.39, for a total transaction of $326,831.46. Following the completion of the transaction, the chief financial officer owned 50,492 shares in the company, valued at approximately $6,836,111.88. The trade was a 4.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Stephen W. Beard sold 2,529 shares of the firm’s stock in a transaction dated Thursday, June 11th. The shares were sold at an average price of $130.78, for a total transaction of $330,742.62. Following the sale, the chief executive officer owned 424,033 shares of the company’s stock, valued at approximately $55,455,035.74. This represents a 0.59% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 15,694 shares of company stock valued at $2,098,614 over the last ninety days. Company insiders own 2.50% of the company’s stock.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.